Connect Sign In
ARUP’s new assay, Influenza A (H5) Virus by Qualitative NAAT (ARUP test number 3018970), will expand the national capacity to detect the current outbreak of highly pathogenic avian influenza A (H5N1). |
January 3, 2025 |
ARUP has launched a new assay for the detection and subtyping of influenza A (H5) virus, which will expand the national capacity to detect |
Benjamin Bradley, MD, PhD, medical director of the ARUP Institute for Research and Innovation in Infectious Disease Genomic Technologies, High Consequence Pathogen Response, Virology, and Molecular Infectious Diseases, participated in a media briefing on avian influenza. |
December 20, 2024 |
ARUP Medical Director: We Are Monitoring H5N1 (Bird Flu) and Have the Capacity To Detect It Benjamin Bradley, MD, PhD, compared the H5N1 outbreak to COVID-19, highlighting the preparedness |
Peng Li, MD, PhD, ARUP medical director, seeks to increase awareness to the newly discovered VEXAS syndrome with a recently published blog and paper. |
December 6, 2024 |
Next generation sequencing (NGS) testing detects UBA1 gene mutations, which are |
Visit booth #2455 at the American Society of Hematopathology (ASH) Annual Meeting and Exposition to speak with ARUP hematopathologists and learn about the latest in laboratory testing for hematologic diseases. |
December 4, 2024 |
ARUP Will Showcase Advances in Hematopathology at the 66th ASH Annual Meeting and Exposition… ARUP medical directors will present key hematopathology research at the 66th ASH Annual |
Presentations by ARUP medical directors and scientists at AMP 2024 included timely topics in molecular pathology such as automated DNA extraction. Melanie Mallory, MS, pictured above, a lead bioinformatics scientist at ARUP, presented a poster related to the prediction of viral loads for cytomegalovirus. |
November 26, 2024 |
ARUP Research Highlighted at the Association for Molecular Pathology 2024 Annual Meeting… ARUP medical directors and scientists presented key molecular pathology advancements at |
|
November 19, 2024 |
A New Edition of Magnify Is Available and Focuses on the FDA’s Rule To Regulate Lab-Developed Tests… This edition features interviews with company leaders describing ARUP’s approaches to |
ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine We accelerate groundbreaking diagnostic and prognostic technologies to drive life-changing innovation. Our large, single-site operation and renowned quality framework, combined with our extensive expertise, provide an ideal incubator to advance custom projects for innovative partners. The Sherrie Perkins Research and Innovation Collaboration Grant The Sherrie Perkins Research and Innovation Collaboration Grant funds cutting-edge research in laboratory medicine.
Test Information
